Article Text

other Versions

PDF
Extended Report
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis
  1. E E A Arts1,
  2. C Popa1,
  3. A A Den Broeder2,
  4. A G Semb3,
  5. T Toms4,
  6. G D Kitas4,
  7. P L van Riel1,
  8. J Fransen1
  1. 1Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands
  2. 2Department of Rheumatology, Maartenskliniek, Nijmegen, The Netherlands
  3. 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  4. 4Department of Rheumatology, Dudley NHS Hospital Group, Dudley, UK
  1. Correspondence to Elke E A Arts, Department of Rheumatology, Radboud University Medical Centre, Geert Grooteplein 8, Nijmegen 6500 HB, The Netherlands; Elke.Arts{at}radboudumc.nl

Abstract

Objective This study was undertaken to assess the predictive ability of 4 established cardiovascular (CV) risk models for the 10-year risk of fatal and non-fatal CV diseases in European patients with rheumatoid arthritis.

Methods Prospectively collected data from the Nijmegen early rheumatoid arthritis (RA) inception cohort was used. Discriminatory ability for CV risk prediction was estimated by the area under the receiver operating characteristic curve. Calibration was assessed by comparing the observed versus expected number of events using Hosmer-Lemeshov tests and calibration plots. Sensitivity and specificity were calculated for the cut-off values of 10% and 20% predicted risk.

Results Areas under the receiver operating characteristic curve were 0.78–0.80, indicating moderate to good discrimination between patients with and without a CV event. The CV risk models Systematic Coronary Risk Evaluation (SCORE), Framingham risk score (FRS) and Reynolds risk score (RRS) primarily underestimated CV risk at low and middle observed risk levels, and mostly overestimated CV risk at higher observed risk levels. The QRisk II primarily overestimated observed CV risk. For the 10% and 20% cut-off values used as indicators for CV preventive treatment, sensitivity ranged from 68–87% and 40–65%, respectively and specificity ranged from 55–76% and 77–88%, respectively. Depending on the model, up to 32% of observed CV events occurred in patients with RA who were classified as low risk (<10%) for CV disease.

Conclusions Established risk models generally underestimate (Systematic Coronary Risk Evaluation score, Framingham Risk Score, Reynolds risk score) or overestimate (QRisk II) CV risk in patients with RA.

Keywords
  • Models Cardiovascular
  • Arthritis Rheumatoid
  • Cardiovascular Disease

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.